Inflammation and cardiovascular diseases: the most recent findings

D Sorriento, G Iaccarino - International journal of molecular sciences, 2019 - mdpi.com
The series of reactive biological events that we identify as inflammation has been
investigated in recent years and unveiled as an important mechanism for regeneration. The …

Inflammation and atherosclerosis

GK Hansson, AKL Robertson… - Annu. Rev. Pathol …, 2006 - annualreviews.org
Atherosclerosis, the cause of myocardial infarction, stroke, and ischemic gangrene, is an
inflammatory disease. The atherosclerotic process is initiated when cholesterol-containing …

[HTML][HTML] Revisiting pharmacology of oxidative stress and endothelial dysfunction in cardiovascular disease: Evidence for redox-based therapies

A Daiber, S Chlopicki - Free Radical Biology and Medicine, 2020 - Elsevier
According to the latest Global Burden of Disease Study data, non-communicable diseases in
general and cardiovascular disease (CVD) in particular are the leading cause of premature …

Exploiting the pleiotropic antioxidant effects of established drugs in cardiovascular disease

S Steven, T Münzel, A Daiber - International journal of molecular sciences, 2015 - mdpi.com
Cardiovascular disease is a leading cause of death and reduced quality of life worldwide.
Arterial vessels are a primary target for endothelial dysfunction and atherosclerosis, which is …

Anti-inflammatory therapeutics for the treatment of atherosclerosis

IF Charo, R Taub - Nature reviews Drug discovery, 2011 - nature.com
Atherosclerosis is the primary cause of heart disease and stroke and is thus the underlying
pathology of the leading causes of death in the western world. Although risk can be reduced …

Oxidative stress, endothelial dysfunction and atherosclerosis

VM Victor, M Rocha, E Sola, C Banuls… - Current …, 2009 - ingentaconnect.com
This review focuses on the role of oxidative processes in atherosclerosis and the
cardiovascular diseases (CVD) that can arise as a result. Atherosclerosis represents a state …

An update on the role of markers of inflammation in atherosclerosis

E Corrado, M Rizzo, G Coppola, K Fattouch… - … of atherosclerosis and …, 2010 - jstage.jst.go.jp
Atherosclerosis is a high-cost disease and its complications still represent the first cause of
death in most industrialized countries. Efficacious prevention includes treatment of the most …

Inflammation: a novel therapeutic target/direction in atherosclerosis

B Li, W Li, X Li, H Zhou - Current Pharmaceutical Design, 2017 - ingentaconnect.com
Over the past two decades, the viewpoint of atherosclerosis has been replaced gradually by
a lipiddriven, chronic, low-grade inflammatory disease of the arterial wall. Current treatment …

[HTML][HTML] Inflammation in atherosclerosis

S Taleb - Archives of cardiovascular diseases, 2016 - Elsevier
Atherosclerosis is an inflammatory disease within the arterial wall that is responsible for
several important adverse vascular events, including coronary artery disease, myocardial …

Inflammatory processes in cardiovascular disease: a route to targeted therapies

N Ruparelia, JT Chai, EA Fisher… - Nature reviews …, 2017 - nature.com
Inflammatory processes are firmly established as central to the development and
complications of cardiovascular diseases. Elevated levels of inflammatory markers have …